Nektar Therapeutics (NKTR) earnings · rev $55.2M
These earnings events as JSON? API free 100/dayNektar Therapeutics (NKTR) is a biotechnology company listed on US.
This NKTR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NKTR revenue for 2025-12-31 was $55.2M. Net income was -$164.1M. Revenue was down 43.9% from 2024-12-31 to 2025-12-31. NKTR currently screens at market cap $307.2M.
When the next NKTR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 43.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NKTR research stays on the stock page; the tape stays on the quote page.
NKTR earnings FAQ
What are NKTR's latest revenue and net income?
Latest cached Nektar Therapeutics (NKTR) revenue for Dec 31, 2025 was $55.2M. Net income was -$164.1M. Statements: https://lician.com/financials/nktr
What is NKTR's latest diluted EPS?
Latest cached Nektar Therapeutics (NKTR) diluted EPS for Dec 31, 2025 was -$9.73.
What period does the latest NKTR earnings print cover?
The latest cached Nektar Therapeutics (NKTR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did NKTR revenue change from the prior cached period?
Cached Nektar Therapeutics (NKTR) revenue was down 43.9% from $98.4M (Dec 31, 2024) to $55.2M (Dec 31, 2025). Statements: https://lician.com/financials/nktr
Where are NKTR earnings listed?
Cached earnings facts for Nektar Therapeutics (NKTR) are listed at https://lician.com/earnings/nktr. Statements: https://lician.com/financials/nktr
Not investment advice.